Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.528
+0.018 (3.61%)
At close: Nov 21, 2024, 4:00 PM
0.530
+0.002 (0.40%)
After-hours: Nov 21, 2024, 4:41 PM EST
Unicycive Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 55 | 30 | 8 | 31 | - | - | |
| Market Cap Growth | 28.78% | 270.11% | -73.58% | - | - | - | |
| Enterprise Value | 23 | 17 | 1 | 13 | - | - | |
| Last Close Price | 0.53 | 0.87 | 0.54 | 2.06 | - | - | |
| PS Ratio | - | 44.68 | 8.57 | - | - | - | |
| PB Ratio | 1.85 | -7.92 | -17.48 | 1.87 | - | - | |
| P/TBV Ratio | 1.38 | - | - | 1.87 | - | - | |
| EV/Sales Ratio | - | 24.77 | 1.40 | - | - | - | |
| Debt / Equity Ratio | 0.03 | -0.21 | -0.33 | 0.02 | -0.94 | -0.52 | |
| Asset Turnover | - | 0.08 | 0.09 | - | - | - | |
| Quick Ratio | 3.09 | 0.55 | 0.14 | 7.88 | - | 0.02 | |
| Current Ratio | 3.61 | 0.76 | 0.81 | 8.75 | 0.07 | 0.02 | |
| Return on Equity (ROE) | -147.05% | - | -225.47% | -145.04% | - | - | |
| Return on Assets (ROA) | -62.85% | -152.67% | -104.65% | -59.22% | -1132.29% | -5111.98% | |
| Return on Capital (ROIC) | -110.63% | - | -136.93% | -67.46% | - | - | |
| Earnings Yield | -43.99% | -101.29% | -221.63% | -32.48% | - | - | |
| FCF Yield | -48.40% | -60.67% | -192.11% | -18.79% | - | - | |
| Buyback Yield / Dilution | -151.45% | -62.98% | -28.96% | -37.37% | -4.68% | -20.35% | |
| Total Shareholder Return | -151.45% | -62.98% | -28.96% | -37.37% | -4.68% | -20.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.